Quispe E Álvaro, Li Xiang-Min, Yi Hong
Emergency Intensive Care Unit, Emergency Department of Xiangya Hospital - Central South University, 87 Xiangya Road, Changsha 410008, China.
Emergency Intensive Care Unit, Emergency Department of Xiangya Hospital - Central South University, 87 Xiangya Road, Changsha 410008, China.
Cytokine. 2016 May;81:94-100. doi: 10.1016/j.cyto.2016.03.004. Epub 2016 Mar 11.
To compare the ability of thyroid hormones, IL-6, IL-10, and albumin to predict mortality, and to assess their relationship in case-mix acute critically ill patients.
APACHE II scores and serum thyroid hormones (FT3, FT4, and TSH), IL-6, IL-10, and albumin were obtained at EICU admission for 79 cases of mix acute critically ill patients without previous history of thyroid disease. Patients were followed for 28 days with patient's death as the primary outcome. All mean values were compared, correlations assessed with Pearson' test, and mortality prediction assessed by multivariate logistic regression and ROC.
Non survivors were older, with higher APACHE II score (p=0.000), IL-6 (p<0.05), IL-10 (p=0.000) levels, and lower albumin (p=0.000) levels compared to survivors at 28 days. IL-6 and IL-10 had significant negative correlation with albumin (p=0.001) and FT3 (p ⩽ 0.05) respectively, while low albumin had a direct correlation with FT3 (p<0.05). In the mortality prediction assessment, IL-10, albumin and APACHE II were independent morality predictors and showed to have a good (0.70-0.79) AUC-ROC (p<0.05). Despite that the entire cohort showed low FT3 serum levels (p=0.000), there was not statistical difference between survivors and non-survivors; neither showed any significance as mortality predictor.
IL-6 and IL-10 are correlated with Low FT3 and hypoalbuminemia. Thyroid hormones assessed at EICU admission did not have any predictive value in our study. And finally, high levels of IL-6 and IL-10 in conjunction with albumin could improve our ability to evaluate disease's severity and predict mortality in the critically ill patients. When use in combination with APACHE II scores, our model showed improved mortality prediction.
比较甲状腺激素、白细胞介素-6(IL-6)、白细胞介素-10(IL-10)和白蛋白预测死亡率的能力,并评估它们在不同病情组合的急性危重症患者中的关系。
对79例既往无甲状腺疾病史的急性危重症混合患者,在进入急诊重症监护病房(EICU)时获取急性生理与慢性健康状况评分系统(APACHE II)评分以及血清甲状腺激素(游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)和促甲状腺激素(TSH))、IL-6、IL-10和白蛋白水平。对患者进行28天的随访,以患者死亡作为主要结局。比较所有均值,用Pearson检验评估相关性,通过多因素逻辑回归和受试者工作特征曲线(ROC)评估死亡率预测情况。
与28天时的存活者相比,非存活者年龄更大,APACHE II评分更高(p = 0.000),IL-6水平更高(p < 0.05),IL-10水平更高(p = 0.000),白蛋白水平更低(p = 0.000)。IL-6和IL-10分别与白蛋白(p = 0.001)和FT3(p≤0.05)呈显著负相关,而低白蛋白与FT3呈直接相关(p < 0.05)。在死亡率预测评估中,IL-10、白蛋白和APACHE II是独立的死亡预测因素,且显示出良好的(0.70 - 0.79)曲线下面积(AUC-ROC)(p < 0.05)。尽管整个队列显示FT3血清水平较低(p = 0.000),但存活者与非存活者之间无统计学差异;FT3作为死亡率预测指标也未显示出任何显著性。
IL-6和IL-10与低FT3和低白蛋白血症相关。在我们的研究中,EICU入院时评估的甲状腺激素没有任何预测价值。最后,高水平的IL-6和IL-10与白蛋白相结合可以提高我们评估危重症患者疾病严重程度和预测死亡率的能力。当与APACHE II评分联合使用时,我们的模型显示出更好的死亡率预测能力。